What happens when a $299 wristband challenges a medical service built around much more expensive equipment?
In this fictional business school case, TrackBP has raised $75 million to bring cuffless ambulatory blood pressure monitoring to market. (One part of the large remote physiological monitoring market, RPM.) Its CEO sees a cleared FDA predicate and an existing CPT code. What could go wrong? Plenty: matching individual readings does not prove accuracy over 48 hours; clearance does not guarantee coverage; and cheaper technology can unsettle reimbursement assumptions.
The case explores where wellness becomes medicine and asks whether FDA, AMA, and CMS can keep pace as familiar services move into radically smaller devices.
Case generated by Chat GPT Astra 1 (10/2026). It should not be used as ground truth, but it can be an example of current abilities of AI to research and write a report.
###
Find the report in the cloud HERE.
